US Patent 10238753 Antisense conjugates for decreasing expression of DMPK
Patent 10238753 was granted and assigned to Valerion Therapeutics on March, 2019 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 10238753 Antisense conjugates for decreasing expression of DMPK
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
